PMID- 38256245 OWN - NLM STAT- MEDLINE DCOM- 20240124 LR - 20240202 IS - 1422-0067 (Electronic) IS - 1422-0067 (Linking) VI - 25 IP - 2 DP - 2024 Jan 18 TI - Programmed Death-Ligand (PD-L1), Epidermal Growth Factor (EGF), Relaxin, and Matrix Metalloproteinase-3 (MMP3): Potential Biomarkers of Malignancy in Canine Mammary Neoplasia. LID - 10.3390/ijms25021170 [doi] LID - 1170 AB - Gene expression has been suggested as a putative tool for prognosis and diagnosis in canine mammary neoplasia (CMNs). In the present study, 58 formalin-fixed paraffin-embedded (FFPE) paraffined canine mammary neoplasias from 27 different bitches were included. Thirty-seven tumours were classified as benign, whereas thirty-one were classified as different types of canine carcinoma. In addition, mammary samples from three healthy bitches were also included. The gene expression for vascular endothelial growth factor-alpha (VEGFalpha), CD20, progesterone receptor (PGR), hyaluronidase-1 (HYAL-1), programmed death-ligand 1 (PD-L1), epidermal growth factor (EGF), relaxin (RLN2), and matrix metalloproteinase-3 (MMP3) was assessed through RT-qPCR. All the assessed genes yielded a higher expression in neoplastic mammary tissue than in healthy tissue. All the evaluated genes were overexpressed in neoplastic mammary tissue, suggesting a role in the process of tumorigenesis. Moreover, PD-L1, EGF, relaxin, and MMP3 were significantly overexpressed in malignant CMNs compared to benign CMNs, suggesting they may be useful as malignancy biomarkers. FAU - Galadima, Makchit AU - Galadima M AD - Department of Animal Medicine and Surgery, Faculty of Veterinary Medicine, Universitat Autonoma de Barcelona, 08193 Bellaterra, Spain. FAU - Teles, Mariana AU - Teles M AD - Department of Cell Biology, Physiology and Immunology, Universitat Autonoma de Barcelona, 08193 Barcelona, Spain. FAU - Pastor, Josep AU - Pastor J AD - Department of Animal Medicine and Surgery, Faculty of Veterinary Medicine, Universitat Autonoma de Barcelona, 08193 Bellaterra, Spain. FAU - Hernandez-Losa, Javier AU - Hernandez-Losa J AUID- ORCID: 0000-0003-1526-3201 AD - Department of Pathology, Hospital Universitari Vall d'Hebron, VHIR, 08035 Barcelona, Spain. FAU - Rodriguez-Gil, Joan Enric AU - Rodriguez-Gil JE AUID- ORCID: 0000-0002-1112-9884 AD - Department of Animal Medicine and Surgery, Faculty of Veterinary Medicine, Universitat Autonoma de Barcelona, 08193 Bellaterra, Spain. FAU - Rivera Del Alamo, Maria Montserrat AU - Rivera Del Alamo MM AUID- ORCID: 0000-0002-9557-4888 AD - Department of Animal Medicine and Surgery, Faculty of Veterinary Medicine, Universitat Autonoma de Barcelona, 08193 Bellaterra, Spain. LA - eng PT - Journal Article DEP - 20240118 PL - Switzerland TA - Int J Mol Sci JT - International journal of molecular sciences JID - 101092791 RN - 62229-50-9 (Epidermal Growth Factor) RN - 9002-69-1 (Relaxin) RN - EC 3.4.24.17 (Matrix Metalloproteinase 3) RN - 0 (B7-H1 Antigen) RN - 0 (Ligands) RN - 0 (Vascular Endothelial Growth Factor A) RN - 0 (Biomarkers) SB - IM MH - Animals MH - Dogs MH - Epidermal Growth Factor/genetics MH - *Relaxin/genetics MH - Matrix Metalloproteinase 3/genetics MH - B7-H1 Antigen MH - Ligands MH - Vascular Endothelial Growth Factor A MH - *Mammary Neoplasms, Animal/genetics MH - Biomarkers PMC - PMC10816983 OTO - NOTNLM OT - canine mammary neoplasia OT - epidermal growth factor OT - gene expression OT - malignancy biomarkers OT - matrix metalloprotease-3 OT - programmed death-ligand 1 OT - relaxin COIS- The authors declare no conflicts of interest. EDAT- 2024/01/23 06:43 MHDA- 2024/01/24 06:42 PMCR- 2024/01/18 CRDT- 2024/01/23 01:13 PHST- 2023/12/11 00:00 [received] PHST- 2024/01/08 00:00 [revised] PHST- 2024/01/16 00:00 [accepted] PHST- 2024/01/24 06:42 [medline] PHST- 2024/01/23 06:43 [pubmed] PHST- 2024/01/23 01:13 [entrez] PHST- 2024/01/18 00:00 [pmc-release] AID - ijms25021170 [pii] AID - ijms-25-01170 [pii] AID - 10.3390/ijms25021170 [doi] PST - epublish SO - Int J Mol Sci. 2024 Jan 18;25(2):1170. doi: 10.3390/ijms25021170.